A headshot of Paolo Martini wearing a white shirt and dark blue suit jacket.

61878-1800-x-900

A 3D rendering of a yellow lipid nanoparticle holding an mRNA therapeutic is shown entering a pink human cell.

61878-1800-x-900-2

Paolo Martini leads the biotech company&rsquo;s rare disease research program with the hope of developing the very first treatments for genetic metabolic disorders.

Moderna&rsquo;s path to mRNA therapies for rare metabolic disorders

Articles

A photo of MJ Kievman, the founder and CEO of Meter Health, who experienced hiccups as a young child and developed Hiccupops, a lollipop to stop hiccups.

img-hiccupops-both-favor-boxes

Ali Seifi, a neurointensivist at the University of Texas, San Antonio who created the HiccAway straw to stop hiccups.

ali-seifi-1

A photo of Mark Fox, a gastroenterologist at the University of Zürich and an expert on hiccups.

mark-fox

Nicole Allard, who experienced chronic hiccups for 15 years, sits atop a hill with red flowers overlooking a valley with green brush and wetlands in Alaska.

chronic-hiccups-cure

An illustration of how the vagus and phrenic nerves stretch across the body and coordinate sensory signals to control the rise and fall of the diaphragm, resulting in the rapid opening and closing of the glottis during a hiccup. 

60759-ddn-nov-2023-print-feature-hiccups-illustration-v2-ic-1

A photo of a blue HiccAway straw, which stops hiccups when sucked on, sitting in a glass of water. 

hiccaway

Two product boxes for the orange citrus and sour apple flavors of Hiccupops. 

A photo of Claudia Bush, an anesthesiologist at the University of Heidelberg, who is building a local patient registry to better understand hiccups. 

Discover causes, treatments, and patient-driven solutions for chronic hiccups, a rare and mysterious condition.

Chronic hiccup chronicles: Causes, treatments, and patient solutions

A 3D illustration of a chromosome (left), the mutated huntingtin gene shown as a piece of DNA (2nd from left), a mutated huntingtin protein (2nd from right), and a neuron showing degeneration (right).

61422

Brain scan showing areas affected by Huntington's disease, with a visual overlay of the gene therapy targeting a specific protein.

Ricardo Dolmetsch wears a dark jacket and glasses while standing outside a building.

uniqure-management-team-ricardo-dolmetsch

A one-time gene therapy aims to stop Huntington&#39;s disease at its source. But first, it has to survive clinical trials.

Gene therapy for Huntington&#39;s disease: A new hope to halt progression

A drawing of a cross-section of a kidney next to a side-view of a kidney with arrows pointing to their different sections as if the diagrams are from an antique anatomy book.

57401-ddn-article-image-protein-elk

A cryo-electron microscope image of LRP2 made up of different colored protein domains is shown in one conformation on the left and in another on the right.

low-res-lrp2-hero-image-1-png

A collaboration of nephrologists and biochemists created the first structure of &ldquo;megalin,&rdquo; a critical protein in kidney and brain disorders.

The intricate design of a fundamental filter protein

News

Discover the most current cell therapy research and the challenges of translating them into the clinic. 

LIVE May 12th, 2022 at 2:30 PM<br>Discover the most current cell therapy research and the challenges of translating them into the clinic.

Cell Therapy Advances: From Benchtop to Bedside

Webinars

ddn-front-cover-december-issue-2025

December 2025

A network of interconnected human icons overlaid on a world map, representing global collaboration and population-scale data connections.

1800x900-1

Illumina

New collaborative initiatives are bringing pharmaceutical R&amp;D together around large-scale datasets to accelerate therapeutic discovery.

Partnering to translate population-scale signals into mechanistic insights for faster drug discovery

Modeling neurotropic viral infections using human cerebral organoids

89801-licorbio-webinar-banners-march-31st-kr1800x900-plain-istock

licorbio-horz-4c-rgb

Li-Cor

Using fetal-stage brain organoids, researchers are uncovering how Zika virus impacts neurodevelopment and contributes to microcephaly.&nbsp;

Completing the real-time data picture in bioprocess development

89778-redshiftbio-webinar-banners-kr1800x900-plain-istock

sebastian-a

redshiftbio-logo

RedShiftBio

Explore approaches to integrating timely protein titer measurements with cell health data to improve bioprocess visibility and decision-making.

genetic disease

Moderna’s path to mRNA therapies for rare metabolic disorders

Chronic hiccup chronicles: Causes, treatments, and patient solutions

Gene therapy for Huntington's disease: A new hope to halt progression

The intricate design of a fundamental filter protein

Cell Therapy Advances: From Benchtop to Bedside

Subscribe to our eNewsletters

Sponsored

December 2025